COVID_19 Clinical Trials in Boston

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Recruiting
  • COVID-19
  • Birmingham, Alabama
  • +39 more
2021-10-11
Oct 11, 2021
E
Active, not recruiting
  • COVID-19
  • Birmingham, Alabama
  • +163 more
2021-10-11
Oct 11, 2021
N
Active, not recruiting
  • COVID-19
  • Placebo
  • +2 more
  • Tucson, Arizona
  • +30 more
2021-10-11
Oct 11, 2021
N
Recruiting
  • COVID-19
  • Lenzilumab
  • +2 more
  • Birmingham, Alabama
  • +61 more
2021-10-11
Oct 11, 2021
R
Terminated
  • COVID-19
  • COVID
  • Pegylated interferon lambda
  • Boston, Massachusetts
    Massachusetts General Hospital
2021-10-04
Oct 4, 2021
F
Completed
  • COVID-19
  • Favipiravir + Standard of Care
  • Standard of Care
  • Scottsdale, Arizona
  • +7 more
2021-09-30
Sep 30, 2021
T
Terminated
  • COVID-19
  • Nitric Oxide
  • Boston, Massachusetts
    Tufts Medical Center
2021-09-23
Sep 23, 2021
B
Recruiting
  • SARS-CoV-2 Infection
  • COVID-19
  • BNT162b2
  • Placebo
  • Athens, Alabama
  • +142 more
2021-09-29
Sep 29, 2021
E
Active, not recruiting
  • COVID-19
  • Birmingham, Alabama
  • +140 more
2021-09-24
Sep 24, 2021
C
Terminated
  • COVID19
  • +2 more
  • Orange, California
  • +20 more
2021-09-23
Sep 23, 2021
R
Completed
  • COVID-19
  • Los Angeles, California
  • +61 more
2021-09-16
Sep 16, 2021
N
W
Recruiting
  • COVID-19
  • Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)
  • La Jolla, California
  • +6 more
2021-09-16
Sep 16, 2021
V
Recruiting
  • COVID-19
  • Lopinavir/Ritonavir 400 mg/100 mg
  • Placebo
  • Aurora, Colorado
  • +6 more
2021-09-09
Sep 9, 2021
V
Recruiting
  • COVID-19
  • +2 more
  • pathogen reduced SARS-CoV-2 convalescent plasma
  • Placebo
  • Little Rock, Arkansas
  • +25 more
2021-08-31
Aug 31, 2021
N
Completed
  • COVID-19
  • Mental Health Disorder
  • Exposure to the SARS-CoV-2
  • Boston, Massachusetts
    Northeastern University
2021-09-02
Sep 2, 2021
H
Active, not recruiting
  • SARS-CoV-2
  • COVID-19
  • Sample collection
  • Birmingham, Alabama
  • +52 more
2021-09-03
Sep 3, 2021
C
Active, not recruiting
  • SARS-CoV-2
  • COVID-19
  • Sample collection
  • Birmingham, Alabama
  • +51 more
2021-09-03
Sep 3, 2021
N
Recruiting
  • SARS-CoV Infection
  • +3 more
  • Moderna COVID-19 Vaccine
  • +2 more
  • Tucson, Arizona
  • +28 more
2021-08-31
Aug 31, 2021
R
Completed
  • COVID-19
  • REGN10933+REGN10987 combination therapy
  • Placebo
  • Birmingham, Alabama
  • +122 more
2021-08-20
Aug 20, 2021
B
Recruiting
  • SARS-CoV-2 Infection
  • COVID-19
  • BNT162b1
  • +3 more
  • Athens, Alabama
  • +165 more
2021-08-25
Aug 25, 2021
S
Terminated
  • Acute Respiratory Distress Syndrome
  • COVID-19
  • Fresno, California
  • +9 more
2021-08-06
Aug 6, 2021
S
Completed
  • COVID-19
  • Chronic Liver Disease
  • Prospective Chart Review
  • Phoenix, Arizona
  • +22 more
2021-08-05
Aug 5, 2021